A large and apprently artificial collection of diverse kinetoplastid protein kinases. A subfamily has 2TM regions, but the majority is cytoplasmic.
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 10 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 35 |
NetGPI | no | yes: 0, no: 35 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 5 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 3 |
GO:0097014 | ciliary plasm | 5 | 3 |
GO:0099568 | cytoplasmic region | 3 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 15 |
GO:0005929 | cilium | 4 | 10 |
GO:0042995 | cell projection | 2 | 10 |
GO:0043226 | organelle | 2 | 12 |
GO:0043227 | membrane-bounded organelle | 3 | 12 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 10 |
GO:0005634 | nucleus | 5 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0005829 | cytosol | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
Related structures:
AlphaFold database: Q4QEJ2
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 36 |
GO:0006793 | phosphorus metabolic process | 3 | 36 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 36 |
GO:0006807 | nitrogen compound metabolic process | 2 | 36 |
GO:0008152 | metabolic process | 1 | 36 |
GO:0009987 | cellular process | 1 | 36 |
GO:0016310 | phosphorylation | 5 | 36 |
GO:0019538 | protein metabolic process | 3 | 36 |
GO:0036211 | protein modification process | 4 | 36 |
GO:0043170 | macromolecule metabolic process | 3 | 36 |
GO:0043412 | macromolecule modification | 4 | 36 |
GO:0044237 | cellular metabolic process | 2 | 36 |
GO:0044238 | primary metabolic process | 2 | 36 |
GO:0071704 | organic substance metabolic process | 2 | 36 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 36 |
GO:0007165 | signal transduction | 2 | 3 |
GO:0035556 | intracellular signal transduction | 3 | 3 |
GO:0050789 | regulation of biological process | 2 | 3 |
GO:0050794 | regulation of cellular process | 3 | 3 |
GO:0065007 | biological regulation | 1 | 3 |
GO:0018105 | peptidyl-serine phosphorylation | 6 | 1 |
GO:0018193 | peptidyl-amino acid modification | 5 | 1 |
GO:0018209 | peptidyl-serine modification | 6 | 1 |
GO:0000281 | mitotic cytokinesis | 4 | 1 |
GO:0000910 | cytokinesis | 3 | 1 |
GO:0022402 | cell cycle process | 2 | 1 |
GO:0061640 | cytoskeleton-dependent cytokinesis | 4 | 1 |
GO:1903047 | mitotic cell cycle process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 36 |
GO:0003824 | catalytic activity | 1 | 36 |
GO:0004672 | protein kinase activity | 3 | 36 |
GO:0005488 | binding | 1 | 36 |
GO:0005524 | ATP binding | 5 | 36 |
GO:0016301 | kinase activity | 4 | 36 |
GO:0016740 | transferase activity | 2 | 36 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 36 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 36 |
GO:0017076 | purine nucleotide binding | 4 | 36 |
GO:0030554 | adenyl nucleotide binding | 5 | 36 |
GO:0032553 | ribonucleotide binding | 3 | 36 |
GO:0032555 | purine ribonucleotide binding | 4 | 36 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 36 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 36 |
GO:0036094 | small molecule binding | 2 | 36 |
GO:0043167 | ion binding | 2 | 36 |
GO:0043168 | anion binding | 3 | 36 |
GO:0097159 | organic cyclic compound binding | 2 | 36 |
GO:0097367 | carbohydrate derivative binding | 2 | 36 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 36 |
GO:1901265 | nucleoside phosphate binding | 3 | 36 |
GO:1901363 | heterocyclic compound binding | 2 | 36 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 22 |
GO:0004707 | MAP kinase activity | 5 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 275 | 279 | PF00656 | 0.314 |
CLV_NRD_NRD_1 | 129 | 131 | PF00675 | 0.209 |
CLV_NRD_NRD_1 | 272 | 274 | PF00675 | 0.261 |
CLV_NRD_NRD_1 | 293 | 295 | PF00675 | 0.418 |
CLV_NRD_NRD_1 | 48 | 50 | PF00675 | 0.243 |
CLV_NRD_NRD_1 | 547 | 549 | PF00675 | 0.610 |
CLV_PCSK_KEX2_1 | 129 | 131 | PF00082 | 0.219 |
CLV_PCSK_KEX2_1 | 272 | 274 | PF00082 | 0.263 |
CLV_PCSK_KEX2_1 | 293 | 295 | PF00082 | 0.432 |
CLV_PCSK_KEX2_1 | 48 | 50 | PF00082 | 0.191 |
CLV_PCSK_KEX2_1 | 516 | 518 | PF00082 | 0.649 |
CLV_PCSK_KEX2_1 | 547 | 549 | PF00082 | 0.578 |
CLV_PCSK_KEX2_1 | 59 | 61 | PF00082 | 0.326 |
CLV_PCSK_KEX2_1 | 63 | 65 | PF00082 | 0.343 |
CLV_PCSK_PC1ET2_1 | 516 | 518 | PF00082 | 0.649 |
CLV_PCSK_PC1ET2_1 | 59 | 61 | PF00082 | 0.332 |
CLV_PCSK_PC1ET2_1 | 63 | 65 | PF00082 | 0.338 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.434 |
CLV_PCSK_SKI1_1 | 130 | 134 | PF00082 | 0.239 |
CLV_PCSK_SKI1_1 | 150 | 154 | PF00082 | 0.312 |
CLV_PCSK_SKI1_1 | 277 | 281 | PF00082 | 0.236 |
CLV_PCSK_SKI1_1 | 28 | 32 | PF00082 | 0.352 |
CLV_PCSK_SKI1_1 | 412 | 416 | PF00082 | 0.380 |
DEG_APCC_DBOX_1 | 442 | 450 | PF00400 | 0.332 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.395 |
DEG_SPOP_SBC_1 | 360 | 364 | PF00917 | 0.299 |
DOC_MAPK_gen_1 | 313 | 321 | PF00069 | 0.467 |
DOC_MAPK_gen_1 | 529 | 537 | PF00069 | 0.532 |
DOC_MAPK_MEF2A_6 | 253 | 261 | PF00069 | 0.241 |
DOC_PP4_FxxP_1 | 192 | 195 | PF00568 | 0.212 |
DOC_USP7_MATH_1 | 110 | 114 | PF00917 | 0.308 |
DOC_USP7_MATH_1 | 361 | 365 | PF00917 | 0.422 |
DOC_USP7_MATH_1 | 434 | 438 | PF00917 | 0.412 |
DOC_USP7_UBL2_3 | 201 | 205 | PF12436 | 0.366 |
DOC_USP7_UBL2_3 | 277 | 281 | PF12436 | 0.216 |
DOC_USP7_UBL2_3 | 525 | 529 | PF12436 | 0.531 |
DOC_USP7_UBL2_3 | 59 | 63 | PF12436 | 0.251 |
DOC_WW_Pin1_4 | 473 | 478 | PF00397 | 0.456 |
LIG_14-3-3_CanoR_1 | 120 | 124 | PF00244 | 0.236 |
LIG_14-3-3_CanoR_1 | 129 | 139 | PF00244 | 0.199 |
LIG_14-3-3_CanoR_1 | 272 | 280 | PF00244 | 0.270 |
LIG_14-3-3_CanoR_1 | 293 | 298 | PF00244 | 0.541 |
LIG_14-3-3_CanoR_1 | 443 | 452 | PF00244 | 0.388 |
LIG_Actin_WH2_2 | 377 | 394 | PF00022 | 0.350 |
LIG_Actin_WH2_2 | 397 | 414 | PF00022 | 0.316 |
LIG_APCC_ABBAyCdc20_2 | 145 | 151 | PF00400 | 0.202 |
LIG_BRCT_BRCA1_1 | 367 | 371 | PF00533 | 0.282 |
LIG_Clathr_ClatBox_1 | 136 | 140 | PF01394 | 0.202 |
LIG_FHA_1 | 131 | 137 | PF00498 | 0.212 |
LIG_FHA_1 | 20 | 26 | PF00498 | 0.654 |
LIG_FHA_1 | 233 | 239 | PF00498 | 0.270 |
LIG_FHA_1 | 502 | 508 | PF00498 | 0.551 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.367 |
LIG_FHA_1 | 78 | 84 | PF00498 | 0.215 |
LIG_FHA_2 | 361 | 367 | PF00498 | 0.445 |
LIG_FHA_2 | 93 | 99 | PF00498 | 0.232 |
LIG_LIR_Apic_2 | 189 | 195 | PF02991 | 0.316 |
LIG_LIR_Apic_2 | 200 | 206 | PF02991 | 0.316 |
LIG_LIR_Gen_1 | 26 | 35 | PF02991 | 0.270 |
LIG_LIR_Gen_1 | 395 | 406 | PF02991 | 0.296 |
LIG_LIR_LC3C_4 | 163 | 166 | PF02991 | 0.313 |
LIG_LIR_Nem_3 | 2 | 6 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 342 | 347 | PF02991 | 0.364 |
LIG_LIR_Nem_3 | 349 | 353 | PF02991 | 0.326 |
LIG_LIR_Nem_3 | 37 | 43 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 395 | 401 | PF02991 | 0.287 |
LIG_SH2_CRK | 203 | 207 | PF00017 | 0.265 |
LIG_SH2_CRK | 350 | 354 | PF00017 | 0.385 |
LIG_SH2_SRC | 108 | 111 | PF00017 | 0.308 |
LIG_SH2_SRC | 268 | 271 | PF00017 | 0.184 |
LIG_SH2_SRC | 358 | 361 | PF00017 | 0.311 |
LIG_SH2_STAT3 | 224 | 227 | PF00017 | 0.200 |
LIG_SH2_STAT3 | 298 | 301 | PF00017 | 0.469 |
LIG_SH2_STAT3 | 4 | 7 | PF00017 | 0.491 |
LIG_SH2_STAT5 | 108 | 111 | PF00017 | 0.408 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.427 |
LIG_SH2_STAT5 | 29 | 32 | PF00017 | 0.393 |
LIG_SH2_STAT5 | 329 | 332 | PF00017 | 0.304 |
LIG_SH2_STAT5 | 352 | 355 | PF00017 | 0.370 |
LIG_SH2_STAT5 | 358 | 361 | PF00017 | 0.366 |
LIG_SH3_2 | 524 | 529 | PF14604 | 0.776 |
LIG_SH3_3 | 521 | 527 | PF00018 | 0.702 |
LIG_SH3_3 | 532 | 538 | PF00018 | 0.536 |
LIG_SUMO_SIM_anti_2 | 403 | 409 | PF11976 | 0.361 |
LIG_SUMO_SIM_par_1 | 255 | 260 | PF11976 | 0.195 |
LIG_SUMO_SIM_par_1 | 377 | 383 | PF11976 | 0.261 |
LIG_TRAF2_1 | 244 | 247 | PF00917 | 0.304 |
LIG_UBA3_1 | 327 | 332 | PF00899 | 0.396 |
LIG_WRC_WIRS_1 | 467 | 472 | PF05994 | 0.297 |
MOD_CK1_1 | 16 | 22 | PF00069 | 0.498 |
MOD_CK1_1 | 419 | 425 | PF00069 | 0.344 |
MOD_CK1_1 | 447 | 453 | PF00069 | 0.325 |
MOD_CK1_1 | 460 | 466 | PF00069 | 0.314 |
MOD_CK1_1 | 483 | 489 | PF00069 | 0.527 |
MOD_CK1_1 | 491 | 497 | PF00069 | 0.507 |
MOD_CK1_1 | 505 | 511 | PF00069 | 0.541 |
MOD_CK1_1 | 518 | 524 | PF00069 | 0.496 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.288 |
MOD_CK2_1 | 119 | 125 | PF00069 | 0.256 |
MOD_CK2_1 | 360 | 366 | PF00069 | 0.329 |
MOD_GlcNHglycan | 15 | 18 | PF01048 | 0.528 |
MOD_GlcNHglycan | 274 | 277 | PF01048 | 0.330 |
MOD_GlcNHglycan | 303 | 306 | PF01048 | 0.539 |
MOD_GlcNHglycan | 310 | 313 | PF01048 | 0.478 |
MOD_GlcNHglycan | 36 | 39 | PF01048 | 0.352 |
MOD_GlcNHglycan | 44 | 47 | PF01048 | 0.284 |
MOD_GlcNHglycan | 459 | 462 | PF01048 | 0.318 |
MOD_GlcNHglycan | 496 | 499 | PF01048 | 0.779 |
MOD_GlcNHglycan | 520 | 523 | PF01048 | 0.734 |
MOD_GSK3_1 | 121 | 128 | PF00069 | 0.287 |
MOD_GSK3_1 | 13 | 20 | PF00069 | 0.516 |
MOD_GSK3_1 | 182 | 189 | PF00069 | 0.315 |
MOD_GSK3_1 | 293 | 300 | PF00069 | 0.591 |
MOD_GSK3_1 | 361 | 368 | PF00069 | 0.393 |
MOD_GSK3_1 | 380 | 387 | PF00069 | 0.413 |
MOD_GSK3_1 | 402 | 409 | PF00069 | 0.367 |
MOD_GSK3_1 | 412 | 419 | PF00069 | 0.316 |
MOD_GSK3_1 | 478 | 485 | PF00069 | 0.505 |
MOD_GSK3_1 | 501 | 508 | PF00069 | 0.537 |
MOD_NEK2_1 | 171 | 176 | PF00069 | 0.295 |
MOD_NEK2_1 | 384 | 389 | PF00069 | 0.263 |
MOD_NEK2_1 | 480 | 485 | PF00069 | 0.615 |
MOD_NEK2_1 | 502 | 507 | PF00069 | 0.525 |
MOD_NEK2_1 | 509 | 514 | PF00069 | 0.533 |
MOD_NEK2_1 | 6 | 11 | PF00069 | 0.388 |
MOD_NEK2_1 | 92 | 97 | PF00069 | 0.251 |
MOD_NEK2_2 | 186 | 191 | PF00069 | 0.220 |
MOD_PIKK_1 | 130 | 136 | PF00454 | 0.257 |
MOD_PIKK_1 | 157 | 163 | PF00454 | 0.315 |
MOD_PIKK_1 | 260 | 266 | PF00454 | 0.240 |
MOD_PIKK_1 | 297 | 303 | PF00454 | 0.467 |
MOD_PIKK_1 | 444 | 450 | PF00454 | 0.403 |
MOD_PIKK_1 | 491 | 497 | PF00454 | 0.744 |
MOD_PKA_1 | 272 | 278 | PF00069 | 0.234 |
MOD_PKA_1 | 293 | 299 | PF00069 | 0.443 |
MOD_PKA_1 | 529 | 535 | PF00069 | 0.647 |
MOD_PKA_2 | 119 | 125 | PF00069 | 0.357 |
MOD_PKA_2 | 272 | 278 | PF00069 | 0.288 |
MOD_PKA_2 | 292 | 298 | PF00069 | 0.426 |
MOD_PKA_2 | 47 | 53 | PF00069 | 0.289 |
MOD_PKA_2 | 491 | 497 | PF00069 | 0.504 |
MOD_Plk_1 | 365 | 371 | PF00069 | 0.554 |
MOD_Plk_1 | 394 | 400 | PF00069 | 0.280 |
MOD_Plk_1 | 92 | 98 | PF00069 | 0.227 |
MOD_Plk_2-3 | 119 | 125 | PF00069 | 0.291 |
MOD_Plk_2-3 | 380 | 386 | PF00069 | 0.254 |
MOD_Plk_4 | 100 | 106 | PF00069 | 0.263 |
MOD_Plk_4 | 171 | 177 | PF00069 | 0.308 |
MOD_Plk_4 | 293 | 299 | PF00069 | 0.439 |
MOD_Plk_4 | 402 | 408 | PF00069 | 0.270 |
MOD_Plk_4 | 466 | 472 | PF00069 | 0.388 |
MOD_Plk_4 | 505 | 511 | PF00069 | 0.520 |
MOD_Plk_4 | 6 | 12 | PF00069 | 0.410 |
MOD_Plk_4 | 79 | 85 | PF00069 | 0.212 |
MOD_ProDKin_1 | 473 | 479 | PF00069 | 0.465 |
MOD_SUMO_for_1 | 528 | 531 | PF00179 | 0.525 |
MOD_SUMO_for_1 | 90 | 93 | PF00179 | 0.308 |
TRG_DiLeu_BaEn_1 | 79 | 84 | PF01217 | 0.260 |
TRG_DiLeu_BaEn_2 | 126 | 132 | PF01217 | 0.286 |
TRG_DiLeu_BaLyEn_6 | 253 | 258 | PF01217 | 0.184 |
TRG_DiLeu_BaLyEn_6 | 323 | 328 | PF01217 | 0.366 |
TRG_DiLeu_BaLyEn_6 | 437 | 442 | PF01217 | 0.422 |
TRG_ENDOCYTIC_2 | 29 | 32 | PF00928 | 0.250 |
TRG_ENDOCYTIC_2 | 341 | 344 | PF00928 | 0.352 |
TRG_ENDOCYTIC_2 | 350 | 353 | PF00928 | 0.474 |
TRG_ENDOCYTIC_2 | 40 | 43 | PF00928 | 0.281 |
TRG_ER_diArg_1 | 129 | 131 | PF00400 | 0.209 |
TRG_ER_diArg_1 | 242 | 245 | PF00400 | 0.191 |
TRG_ER_diArg_1 | 272 | 274 | PF00400 | 0.234 |
TRG_Pf-PMV_PEXEL_1 | 130 | 134 | PF00026 | 0.465 |
TRG_Pf-PMV_PEXEL_1 | 326 | 331 | PF00026 | 0.306 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2S2 | Leptomonas seymouri | 68% | 99% |
A0A0S4JTJ8 | Bodo saltans | 30% | 100% |
A0A1X0NTP1 | Trypanosomatidae | 49% | 95% |
A0A3Q8IB74 | Leishmania donovani | 31% | 100% |
A0A3Q8IFW0 | Leishmania donovani | 31% | 100% |
A0A3Q8IH39 | Leishmania donovani | 27% | 100% |
A0A3Q8IIG1 | Leishmania donovani | 26% | 100% |
A0A3Q8INQ4 | Leishmania donovani | 29% | 100% |
A0A3Q8ITZ9 | Leishmania donovani | 26% | 100% |
A0A3Q8IVR8 | Leishmania donovani | 31% | 100% |
A0A3R7MKJ1 | Trypanosoma rangeli | 45% | 100% |
A0A3S5H4Z4 | Leishmania donovani | 26% | 100% |
A0A3S5H528 | Leishmania donovani | 26% | 100% |
A0A3S5H5G0 | Leishmania donovani | 28% | 100% |
A0A3S5H6C8 | Leishmania donovani | 22% | 100% |
A0A3S5H7N7 | Leishmania donovani | 27% | 100% |
A0A3S7WQK7 | Leishmania donovani | 22% | 100% |
A0A3S7WR45 | Leishmania donovani | 27% | 100% |
A0A3S7WTN9 | Leishmania donovani | 33% | 100% |
A0A3S7WUE7 | Leishmania donovani | 97% | 100% |
A0A3S7X7Y2 | Leishmania donovani | 30% | 100% |
A0A3S7X933 | Leishmania donovani | 29% | 100% |
A0A3S7X9R4 | Leishmania donovani | 30% | 100% |
A0A451EJH2 | Leishmania donovani | 24% | 100% |
A4H3D2 | Leishmania braziliensis | 24% | 100% |
A4H3J3 | Leishmania braziliensis | 26% | 100% |
A4H459 | Leishmania braziliensis | 28% | 100% |
A4H5L7 | Leishmania braziliensis | 23% | 100% |
A4H601 | Leishmania braziliensis | 27% | 100% |
A4H641 | Leishmania braziliensis | 26% | 100% |
A4H8C4 | Leishmania braziliensis | 34% | 100% |
A4H8V2 | Leishmania braziliensis | 87% | 100% |
A4H9X5 | Leishmania braziliensis | 31% | 100% |
A4HAS1 | Leishmania braziliensis | 30% | 100% |
A4HED7 | Leishmania braziliensis | 29% | 100% |
A4HHN1 | Leishmania braziliensis | 29% | 100% |
A4HIM5 | Leishmania braziliensis | 26% | 100% |
A4HJW2 | Leishmania braziliensis | 30% | 100% |
A4HLJ9 | Leishmania braziliensis | 27% | 100% |
A4HMJ3 | Leishmania braziliensis | 29% | 100% |
A4HN71 | Leishmania braziliensis | 29% | 100% |
A4HNT2 | Leishmania braziliensis | 32% | 100% |
A4HRM6 | Leishmania infantum | 26% | 100% |
A4HRN3 | Leishmania infantum | 24% | 100% |
A4HRT2 | Leishmania infantum | 26% | 100% |
A4HSE2 | Leishmania infantum | 28% | 100% |
A4HTV4 | Leishmania infantum | 22% | 100% |
A4HTV5 | Leishmania infantum | 22% | 100% |
A4HUC8 | Leishmania infantum | 27% | 100% |
A4HUG1 | Leishmania infantum | 27% | 100% |
A4HWP5 | Leishmania infantum | 33% | 100% |
A4HX71 | Leishmania infantum | 97% | 100% |
A4I1T4 | Leishmania infantum | 29% | 100% |
A4I435 | Leishmania infantum | 26% | 100% |
A4I5X0 | Leishmania infantum | 27% | 100% |
A4I7C4 | Leishmania infantum | 31% | 100% |
A4I910 | Leishmania infantum | 27% | 100% |
A4I9Y5 | Leishmania infantum | 30% | 100% |
A4IB73 | Leishmania infantum | 29% | 100% |
A4IBT4 | Leishmania infantum | 30% | 100% |
A4IBT9 | Leishmania infantum | 30% | 100% |
A4ICR2 | Leishmania infantum | 31% | 100% |
C9ZTU6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 100% |
E8NHK0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 100% |
E9ACB1 | Leishmania major | 25% | 100% |
E9ACG8 | Leishmania major | 26% | 100% |
E9AEZ4 | Leishmania major | 29% | 100% |
E9AGS0 | Leishmania infantum | 31% | 100% |
E9AJJ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 100% |
E9AJJ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
E9AKB7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 100% |
E9AKZ7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
E9AMP2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 23% | 100% |
E9AN28 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
E9AN59 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
E9AQF3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E9ARC8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
E9ARW9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E9ASJ2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
E9AXW8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9B164 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 27% | 100% |
E9B2B7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E9B3X5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 100% |
E9B4Z4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
E9B650 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9B6S4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 30% | 100% |
E9B6S9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
E9B727 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 29% | 100% |
O80673 | Arabidopsis thaliana | 30% | 96% |
P00518 | Oryctolagus cuniculus | 28% | 100% |
Q16816 | Homo sapiens | 28% | 100% |
Q4Q204 | Leishmania major | 31% | 100% |
Q4Q2Z2 | Leishmania major | 30% | 100% |
Q4Q449 | Leishmania major | 26% | 100% |
Q4Q701 | Leishmania major | 27% | 100% |
Q4Q9K2 | Leishmania major | 29% | 100% |
Q4QDK3 | Leishmania major | 31% | 100% |
Q4QF23 | Leishmania major | 34% | 100% |
Q4QHG6 | Leishmania major | 27% | 100% |
Q4QHJ8 | Leishmania major | 27% | 100% |
Q4QHY3 | Leishmania major | 22% | 100% |
Q4QHY4 | Leishmania major | 22% | 100% |
Q4QJJ0 | Leishmania major | 28% | 100% |
Q9GNR4 | Leishmania major | 30% | 100% |
Q9LET1 | Arabidopsis thaliana | 30% | 96% |
V5BH88 | Trypanosoma cruzi | 45% | 100% |